Diabetes Drugs Under Scrutiny As FDA Considers Another Study

Diabetes Drugs Under Scrutiny As FDA Considers Another Study

Submitted by admin on June 12, 2013 - 12:40pm
Source: 
Pharmalot
News Tags: 
FDA
diabetes
Merck
Januvia
Onglyza
Bristol-Myers Squibb
Byetta
AstraZeneca
Eli Lilly
Novo Nordisk
Victoza
Tradjenta
Boehringer Ingelheim
Headline: 
Diabetes Drugs Under Scrutiny As FDA Considers Another Study

Do Not Allow Advertisers to Use My Personal information